University Health Network, Toronto General Hospital, Multi-Organ Transplant
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kumar, Deepali
NCT03493776: Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation

Active, not recruiting
4
50
Canada
VZV subunit vaccine
Deepali Kumar
Varicella Zoster Vaccine
09/19
04/21
RSV OA=ADJ-023, NCT05921903: A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

Active, not recruiting
2
387
Europe, Canada, Japan, US, RoW
RSVPreF3 OA Investigational Vaccine
GlaxoSmithKline
Respiratory Syncytial Virus Infections
07/24
06/25
NCT04507477: Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial

Recruiting
1/2
10
Canada
Rituximab, Rituxan
University Health Network, Toronto
Epstein-Barr Virus Infections, Post-transplant Lymphoproliferative Disorder
12/22
02/23
Humar, Atul
No trials found
Kumar, Deeplai
No trials found

Download Options